Tuani, Renalyn C.

HRN: 11-89-84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/21/2025
CEFUROXIME 500MG (TAB)
11/21/2025
11/27/2025
PO
500mg
BID
SP NSVD
Checking Initial Appropriateness 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines